Michelle Johnson

Clostridium difficile Ribotype Diversity at Six Health Care Institutions in the United States

Sarah A. Ewing, D. Aronoff, W. Dunne, 2013, Journal of Clinical Microbiology.

Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma PatientsTreated With Immune Checkpoint Inhibitors or Enfortumab Vedotin.

Julian C. Hong, M. Meng, R. Bose, 2023, Clinical genitourinary cancer.

Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence.

D. Reda, R. Ringer, C. Donskey, 2022, Contemporary Clinical Trials.